Hjem › Dermatomyositt › Pennsylvania › Philadelphia
Kliniske studier for Dermatomyositt i Philadelphia, PA
4 studier for Dermatomyositt søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RekruttererFase 3
- Research Site, Philadelphia
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekruttererFase 2/3
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RekruttererFase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
RekruttererObservasjonsstudie
- Hospital of the University of Pennsylvania, Philadelphia
Dermatomyositt-studier i andre byer
- Durham, NC8 studier
- Washington, DC7 studier
- New York City, NY5 studier
- Boston, MA5 studier
- Pittsburgh, PA5 studier
- Houston, TX5 studier
- Miami, FL4 studier
- Baltimore, MD4 studier
- Aurora, CO3 studier
- Kansas City, KS3 studier
- Jacksonville, FL3 studier
- Phoenix, AZ3 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.